Embecta (Embecta) Accounts Payable & Accrued Expense : $297 Mil (As of Mar. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Embecta Accounts Payable & Accrued Expense?

Embecta's quarterly accounts payable & accrued expense declined from Sep. 2023 ($340 Mil) to Dec. 2023 ($313 Mil) and declined from Dec. 2023 ($313 Mil) to Mar. 2024 ($297 Mil).

Embecta's annual accounts payable & accrued expense increased from Sep. 2021 ($164 Mil) to Sep. 2022 ($288 Mil) and increased from Sep. 2022 ($288 Mil) to Sep. 2023 ($340 Mil).

Embecta Accounts Payable & Accrued Expense Historical Data

The historical data trend for Embecta's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Embecta Accounts Payable & Accrued Expense Chart

Embecta Annual Data

Trend

Sep19

Sep20

Sep21

Sep22

Sep23

Accounts Payable & Accrued Expense

137.00

164.00

287.90

340.40

Embecta Quarterly Data
	Sep19	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial											344.60	372.70	340.40	313.40	297.20

Embecta Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Embecta (Embecta) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Embecta Corp (NAS:EMBC) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

JX7:Germany

Address

300 Kimball Drive, Suite 300, Parsippany, NJ, USA, 07054

Website

https://www.embecta.com

Embecta Corp is a medical technology company. The company develops innovative technology, services, and solutions that help advance both clinical therapy for patients and clinical processes for healthcare providers. Its products include BD Pyxis, PureWick, Phasix among others.

Executives

David F Melcher	director	1650 TYSONS BOULEVARD, SUITE 1700, MCLEAN VA 22102
Devdatt Kurdikar	officer: President and CEO	ONE BECTON DRIVE, FRANKLIN LAKES NJ 07417
Jacob Elguicze	officer: Chief Financial Officer	ONE BECTON DRIVE, FRANKLIN LAKES NJ 07417
Jeffrey Z Mann	officer: SVP, GC, Head Corp. Dev., Secy	150 CLOVE ROAD, 9TH FLOOR, LITTLE FALLS NJ 07424
Jean Casner	officer: Chief Human Resources Officer	150 CLOVE ROAD, LITTLE FALLS NJ 07424
Karen Prange	director	1108 S RIO VISTA BLVD, FORT LAUDERDALE FL 33316
Ajay Kumar	officer: SVP and CHRO	C/O EMBECTA CORP., ONE BECTON DRIVE, FRANKLIN LAKES NJ 07417
Shaun Curtis	officer: SVP, Global Manuf./Sup. Chain	C/O EMBECTA CORP., ONE BECTON DRIVE, FRANKLIN LAKES NJ 07417
David Albritton	director	ONE BECTON DRIVE, FRANKLIN LAKES NJ 07417-1880
Milton Mayo Morris	director	2121 ALLEN PARKWAY, APT 4075, HOUSTON TX 77019
Brian Capone	officer: VP, CAO & Corp. Controller	150 CLOVE ROAD, 9TH FLOOR, LITTLE FALLS NJ 07424
Carrie L Anderson	director	3005 HIGHLAND PARKWAY, SUITE 200, DOWNERS GROVE IL 60515
Claire Pomeroy	director	BECTON, DICKINSON AND COMPANY, 1 BECTON DRIVE, FRANKLIN LAKES NJ 07417
Christopher R Reidy	director	ONE ADP BLVD, ROSELAND NJ 07068
Robert J. Hombach	director	C/O BAXALTA INCORPORATED, 1200 LAKESIDE DRIVE, BANNOCKBURN IL 60015